Osteoporosis Evaluation and Treatment: From DXA Scan to Therapeutic Decision
Auryan Szalat, MD
Department of Medicine
Hadassah Mount Scopus Hospital
Upon completion of this lecture, participants will be able to:
1) Accurately use DXA scan and FRAX to diagnose osteoporosis and classify risk fracture
2) Accurately use DXA scan, TBS and TBS-adjusted FRAX to diagnose osteoporosis and classify risk fracture
3) Appropriately request a VFA and/or a single energy femur analysis for specific patients
Credit: 1 AMA PRA Category 1 Credit™
1 Category A CE Credit
Scroll to the bottom to complete the survey and take the quiz
NO CONFLICT OF INTEREST DISCLOSURE
None of the planners/faculty for this educational activity have a relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, or re-selling, or distributing healthcare products used by or on patients
Instructions: After watching the video, scroll to the bottom, complete a post-event online quiz and evaluation. After passing the quiz and submitting evaluation, your CME certificate will be available for download
Accreditation and Disclosure
World Class CME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
World Class CME designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The American Society of Radiologic Technologists credit is pending for this activity for Category A CE credits as follows. The American Registry of Diagnostic Medical Sonographers (ARDMS) accepts all American Society of Radiologic Technologists (ASRT) Category A credits as fulfilling their requirements for continuing education (CE) credits.
This program has been planned and implemented in accordance with ACCME essentials and standards. World Class CME relies on its CME faculty to provide program content that is evidence-based and free of commercial bias. Therefore, any faculty, program director, reviewer and/or provider industry relationships will be disclosed and resolved. Speakers are required to openly disclose any limitations of data and/or any discussion of any off-label, experimental, or investigational uses of drugs or devices in their presentations.
This activity is supported by an unrestricted educational grant from Hologic, Inc.
Release Date: 7/18/2022
Expiry Date: 8/1/2025
Certificate Fee: Free